Epigenetic regulation of adipogenesis

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 15, Issue 4, 2012, Pages 342-349

  Musri, Melina M ^a,c   Párrizas, Marcelina ^b  

^a Hospital Clinic   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

adipogenesis; chromatin; histone; microRNAs; transcriptional hotspots

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRANSCRIPTION FACTOR;

ADIPOCYTE; ADIPOGENESIS; CELL DIFFERENTIATION; CHROMATIN; EPIGENETICS; GENETIC TRANSCRIPTION; HIGH THROUGHPUT SCREENING; HUMAN; METABOLISM; NONHUMAN; PHENOTYPE; PROTEIN MODIFICATION; REVIEW;

ADIPOCYTES; ADIPOGENESIS; ANIMALS; CCAAT-ENHANCER-BINDING PROTEINS; CHROMATIN; EPIGENESIS, GENETIC; HUMANS; OBESITY; PHENOTYPE; PPAR GAMMA; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84862142572     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e3283546fba     Document Type: Review

References (67)

1. Cristancho AG, Lazar MA. Forming functional fat: a growing understanding of adipocyte differentiation. Nat Rev Mol Cell Biol 2011; 12:722-734
2. Lefterova MI, Lazar MA. New developments in adipogenesis. Trends Endocrinol Metab 2009; 20:107-114
3. Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol 2010; 316:129-139
4. Maury E, Brichard SM. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol 2010; 314:1-16
5. Khandekar MJ, Cohen P, Spiegelman BM. Molecular mechanisms of cancer development in obesity. Nat Rev Cancer 2011; 11:886-895
6. Tchkonia T, Pirtskhalava T, Thomou T, et al. Increased TNFa and CCAAT/enhancer-binding protein homologous protein with aging predispose preadipocytes to resist adipogenesis. Am J Physiol Endocrinol Metab 2007; 293:E1810-E1819
7. Tchoukalova Y, Koutsari C, Jensen M. Committed subcutaneous preadipocytes are reduced in human obesity. Diabetologia 2007; 50:151-157
8. Lefterova MI, Zhang Y, Steger DJ, et al. PPARg and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale. Genes Dev 2008; 22:2941-2952
9. Nielsen R, Pedersen TA, Hagenbeek D, et al. Genome-wide profiling of PPARg:RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis. Genes Dev 2008; 22:2953-2967
10. Barak Y, Nelson MC, Ong ES, et al. PPARg is required for placental, cardiac, and adipose tissue development. Mol Cell 1999; 4:585-595
11. Rosen ED, Sarraf P, Troy AE, et al. PPARg is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell 1999; 4:611-617
12. Rosen ED, Hsu CH, Wang X, et al. C/EBPa induces adipogenesis through PPARg: a unified pathway. Genes Dev 2002; 16:22-26
13. Musri MM, Gomis R, Parrizas M. Chromatin and chromatin-modifying proteins in adipogenesis. Biochem Cell Biol 2007; 85:397-410
14. Seale P, Kajimura S, Yang W, et al. Transcriptional control of brown fat determination by PRDM16. Cell Metab 2007; 6:38-54
15. Schulz TJ, Huang TL, Tran TT, et al. Identification of inducible brown adipocyte progenitors residing in skeletal muscle and white fat. Proc Natl Acad Sci USA 2011; 108:143-148
16. Sun L, Xie H, Mori MA, et al. Mir193b-365 is essential for brown fat differentiation. Nat Cell Biol 2011; 13:958-965
17. Mudhasani R, Imbalzano AN, Jones SN. An essential role for Dicer in adipocyte differentiation. J Cell Biochem 2010; 110:812-816
18. Mudhasani R, Puri V, Hoover K, et al. Dicer is required for the formation of white but not brown adipose tissue. J Cell Physiol 2011; 226:1399-1406
19. Bengestrate L, Virtue S, Campbell M, et al. Genome-wide profiling of micro-RNAs in adipose mesenchymal stem cell differentiation and mouse models of obesity. PLoS ONE 2011; 6:e21305
20. Keller P, Gburcik V, Petrovic N, et al. Gene-chip studies of adipogenesisregulated microRNAs in mouse primary adipocytes and human obesity. BMC Endocr Disord 2011; 11:7
21. Li G, Li Y, Li X, et al. MicroRNA identity and abundance in developing swine adipose tissue as determined by Solexa sequencing. J Cell Biochem 2011; 112:1318-1328
22. Karbiener M, Neuhold C, Opriessnig P, et al. MicroRNA-30c promotes human adipocyte differentiation and co-represses PAI-1 and ALK2. RNA Biol 2011; 8:850-860
23. Skarn M, Namlos HM, Noordhuis P, et al. Adipocyte differentiation of human bone marrow-derived stromal cells is modulated by microRNA-155, micro-RNA-221, and microRNA-222. Stem Cells Dev 2012; 21:873-883
24. Zaragosi LE, Wdziekonski B, Brigand KL, et al. Small RNA sequencing reveals miR-642a-3p as a novel adipocyte-specific microRNA and miR-30 as a key regulator of human adipogenesis. Genome Biol 2011; 12:R64
25. Zhang JF, Fu WM, He ML, et al. MiR-637 maintains the balance between adipocytes and osteoblasts by directly targeting Osterix. Mol Biol Cell 2011; 22:3955-3961
26. Qin L, Chen Y, Niu Y, et al. A deep investigation into the adipogenesis mechanism: profile of microRNAs regulating adipogenesis by modulating the canonical Wnt/beta-catenin signaling pathway. BMC Genomics 2010; 11:320
27. Bork S, Horn P, Castoldi M, et al. Adipogenic differentiation of human mesenchymal stromal cells is down-regulated by microRNA-369-5p and up-regulated by microRNA-371. J Cell Physiol 2011; 226:2226-2234
28. Hupkes M, van Someren EP, Middelkamp SH, et al. DNA methylation restricts spontaneous multilineage differentiation of mesenchymal progenitor cells, but is stable during growth factor-induced terminal differentiation. Biochim Biophys Acta 2011; 1813:839-849
29. Jin Q, Zhang F, Yan T, et al. C/EBPa regulates SIRT1 expression during adipogenesis. Cell Res 2010; 20:470-479
30. Kim YJ, Hwang SH, Lee SY, et al. miR-486-5p induces replicative senescence of human adipose tissue-derived mesenchymal stem cells and its expression is controlled by high glucose. Stem Cells Dev 2011. [Epub ahead of print]. doi: 10.1089/scd.2011.0429
31. Cohen-Kfir E, Artsi H, Levin A, et al. Sirt1 is a regulator of bone mass and a repressor of Sost encoding for sclerostin, a bone formation inhibitor. Endocrinology 2011; 152:4514-4524
32. Razidlo DF, Whitney TJ, Casper ME, et al. Histone deacetylase 3 depletion in osteo/chondroprogenitor cells decreases bone density and increases marrow fat. PLoS ONE 2010; 5:e11492
33. Chen YH, Yeh FL, Yeh SP, et al. Myocyte enhancer factor-2 interacting transcriptional repressor (MITR) is a switch that promotes osteogenesis and inhibits adipogenesis of mesenchymal stem cells by inactivating peroxisome proliferator-activated receptor gamma-2. J Biol Chem 2011; 286:10671-10680
34. Wang L, Jin Q, Lee JE, et al. Histone H3K27 methyltransferase Ezh2 represses Wnt genes to facilitate adipogenesis. Proc Natl Acad Sci USA 2010; 107:7317-7322
35. Tchkonia T, Morbeck DE, Von ZT, et al. Fat tissue, aging, and cellular senescence. Aging Cell 2010; 9:667-684
36. Haberland M, Carrer M, Mokalled MH, et al. Redundant control of adipogenesis by histone deacetylases 1 and 2. J Biol Chem 2010; 285:14663-14670
37. Siersbaek R, Nielsen R, John S, et al. Extensive chromatin remodelling and establishment of transcription factor 'hotspots' during early adipogenesis. EMBO J 2011; 30:1459-1472
38. Steger DJ, Grant GR, Schupp M, et al. Propagation of adipogenic signals through an epigenomic transition state. Genes Dev 2010; 24:1035-1044
39. Zhang YY, Li X, Qian SW, et al. Transcriptional activation of histone H4 by C/EBPb during the mitotic clonal expansion of 3T3-L1 adipocyte differentiation. Mol Biol Cell 2011; 22:2165-2174
40. Mikkelsen TS, Xu Z, Zhang X, et al. Comparative epigenomic analysis of murine and human adipogenesis. Cell 2010; 143:156-169
41. Lo KA, Bauchmann MK, Baumann AP, et al. Genome-wide profiling of H3K56 acetylation and transcription factor binding sites in human adipocytes. PLoS ONE 2011; 6:e19778
42. Waki H, Nakamura M, Yamauchi T, et al. Global mapping of cell type-specific open chromatin by FAIRE-seq reveals the regulatory role of the NFI family in adipocyte differentiation. PLoS Genet 2011; 7:e1002311
43. Eguchi J, Yan QW, Schones DE, et al. Interferon regulatory factors are transcriptional regulators of adipogenesis. Cell Metab 2008; 7:86-94
44. Eguchi J, Wang X, Yu S, et al. Transcriptional control of adipose lipid handling by IRF4. Cell Metab 2011; 13:249-259
45. Sato-Kusubata K, Jiang Y, Ueno Y, Chun TH. Adipogenic histone mark regulation by matrix metalloproteinase 14 in collagen-rich microenvironments. Mol Endocrinol 2011; 25:745-753
46. Musri MM, Corominola H, Casamitjana R, et al. Histone H3 lysine 4 dimethylation signals the transcriptional competence of the adiponectin promoter in preadipocytes. J Biol Chem 2006; 281:17180-17188
47. Yoo EJ, Chung JJ, Choe SS, et al. Down-regulation of histone deacetylases stimulates adipocyte differentiation. J Biol Chem 2006; 281:6608-6615
48. Chatterjee TK, Idelman G, Blanco V, et al. Histone deacetylase 9 is a negative regulator of adipogenic differentiation. J Biol Chem 2011; 286:27836-27847
49. Abdou HS, Atlas E, Hache RJ. Liver-enriched inhibitory protein (LIP) actively inhibits preadipocyte differentiation through histone deacetylase 1 (HDAC1). J Biol Chem 2011; 286:21488-21499
50. Nebbioso A, Dell'Aversana C, Bugge A, et al. HDACs class II-selective inhibition alters nuclear receptor-dependent differentiation. J Mol Endocrinol 2010; 45:219-228
51. Musri MM, Gomis R, Parrizas M. A chromatin perspective of adipogenesis. Organogenesis 2010; 6:15-23
52. Musri MM, Carmona MC, Hanzu FA, et al. Histone demethylase LSD1 regulates adipogenesis. J Biol Chem 2010; 285:30034-30041
53. Okamura M, Inagaki T, Tanaka T, Sakai J. Role of histone methylation and demethylation in adipogenesis and obesity. Organogenesis 2010; 6:24-32
54. Xiao H, Leblanc SE, Wu Q, et al. Chromatin accessibility and transcription factor binding at the PPARg2 promoter during adipogenesis is protein kinase A-dependent. J Cell Physiol 2011; 226:86-93
55. Cristancho AG, Schupp M, Lefterova MI, et al. Repressor transcription factor 7-like 1 promotes adipogenic competency in precursor cells. Proc Natl Acad Sci USA 2011; 108:16271-16276
56. Schmidt SF, Jorgensen M, Chen Y, et al. Cross species comparison of C/EBPa and PPARg profiles in mouse and human adipocytes reveals interdependent retention of binding sites. BMC Genomics 2011; 12:152
57. Lefterova MI, Steger DJ, Zhuo D, et al. Cell-specific determinants of PPARg function in adipocytes and macrophages. Mol Cell Biol 2010; 30:2078-2089
58. Yu CY, Mayba O, Lee JV, et al. Genome-wide analysis of glucocorticoid receptor binding regions in adipocytes reveal gene network involved in triglyceride homeostasis. PLoS ONE 2010; 5:e15188
59. Soccio RE, Tuteja G, Everett LJ, et al. Species-specific strategies underlying conserved functions of metabolic transcription factors. Mol Endocrinol 2011; 25:694-706
60. Lizcano F, Romero C, Vargas D. Regulation of adipogenesis by nuclear receptor PPARg is modulated by the histone demethylase JMJD2C. Genet Mol Biol 2011; 34:19-24
61. Park UH, Yoon SK, Park T, et al. Additional sex comb-like (ASXL) proteins 1 and 2 play opposite roles in adipogenesis via reciprocal regulation of PPARg. J Biol Chem 2011; 286:1354-1363
62. Erener S, Hesse M, Kostadinova R, Hottiger MO. Poly(ADP-Ribose) Polymerase-1 (PARP1) Controls Adipogenic Gene Expression and Adipocyte Function. Mol Endocrinol 2011; 26:79-86
63. Herrera BM, Lockstone HE, Taylor JM, et al. Global microRNA expression profiles in insulin target tissues in a spontaneous rat model of type 2 diabetes. Diabetologia 2010; 53:1099-1109
64. Lavebratt C, Almgren M, Ekstrom TJ. Epigenetic regulation in obesity. Int J Obes (Lond) 2011; 10
65. Roldan M, Macias-Gonzalez M, Garcia R, et al. Obesity short-circuits stemness gene network in human adipose multipotent stem cells. FASEB J 2011; 25:4111-4126
66. Zhang J, Henagan TM,Gao Z, Ye J. Inhibition of glyceroneogenesis by histone deacetylase 3 contributes to lipodystrophy in mice with adipose tissue inflammation. Endocrinology 2011; 152:1829-1838
67. Skinner MK. Environmental epigenomics and disease susceptibility. EMBO Rep 2011; 12:620-622